Connect with us

coronavirus

European Health Union: Commission establishes portfolio of ten most promising treatments for COVID-19

SHARE:

Published

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

The Commission has made a decisive contribution to the COVID-19 treatment strategy by establishing a portfolio of ten potential COVID-19 treatments. Based on independent scientific opinions, this list concerns candidate treatments against COVID-19 in the process of being authorized and which should therefore soon be available on the European market. Once the safety and efficacy of these treatments have been confirmed by the European Medicines Agency, patients will have access to them as quickly as possible across the Union. Promoting Our European Way of Life Vice President Margaritis Schinas said: “As we continue to meet the challenge of COVID-19, it is important to have, in addition to vaccination, other ways to protect yourself. With this list of ten treatments for COVID-19, citizens will benefit from the most promising treatments against the virus."

Health and Food Safety Commissioner Stella Kyriakides (pictured) said: "Vaccination is the only way to avoid hospitalizations and deaths linked to COVID and therefore the only way out of this pandemic. In the meantime, however, patients need safe and effective treatments that can fight infection, improve the chances of a speedy recovery, reduce hospital admissions, and most importantly, prevent loss of life. human. We have already signed four joint procurement contracts for different treatments related to COVID-19 and we are ready to negotiate more. Our aim is to allow at least three treatments in the coming weeks, and possibly two more by the end of the year, and to help member states access them as soon as possible. "

Share this article:

Share this:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.

Trending